MAPK3 and bronchopulmonary dysplasia: Our particular focus was on the impact of activating p-ERK1/2 on proliferation, transdifferentiation, and migration of lung fibroblasts, and the molecular mechanism(s) by which activation of ERK1/2 modulates the progression of BPD.